The ICTUS study: A prospective longitudinal observational study of 1,380 AD patients in Europe: Study design and baseline characteristics of the cohort

Neuroepidemiology

Volumn 29, Issue 1-2, 2007, Pages 29-38

  Reynish, E ^a,b,c,c   Cortes, F ^a,b,c   Andrieu, S ^a,b,c   Cantet, C ^a,b,c   Olde Rikkert, M ^d,j   Melis, R ^d   Froelich, L ^g,j   Frisoni, G ^j   Jonsson L ⁱ   Visser, P J ^e,f   Ousset, P J ^a,b,c   Vellas, B ^a,b,c,j   Jones, R W ^j   Burns, A ^j   Bullock, R ^j   Malick, A ^j   Salmon, E ^j   Waldemar, G ^j   Dartigues, J F ^j   Pasquier, F ^j   Touchon, J ^j   Robert, Ph ^j   Rigaud, A S ^j   Camus, V ^j   Stiens, G ^j   Costa Tsolaki, M ^j   Rodriguez, G ^j   Cherubini, A ^j   Spiru, L ^j   Boada, M ^j   Salva, A ^j   Aguera Morales E ^j   Ribera Casado, J M ^j   Lage, P M ^j   Winblad, B ^j   Eriksdotter Jonhagen M ^j   Michel, J P ^j   Scheltens, P ^j   more..

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

ⁱ Innovus   (Sweden)

^j Toulouse University Hospitals ^*

more..

Author keywords

Alzheimer's disease; Clinical Dementia Rating; Cohort, longitudinal study; Cross sectional data; Dementia; Multicentre study, Europe; Neurodegenerative disease; Observational study

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COMORBIDITY; EDUCATION; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHIATRY; PROSPECTIVE STUDY; SOCIOECONOMICS;

EID: 36549016584     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108915     Document Type: Article

References (55)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M: Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-2117.
2. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di CA, Breteler MM, Copeland JR, Dartigues JF, Jagger C, Martinez-Lage J, Soininen H, Hofman A: Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54:S4-S9.
3. Maurer K, Volk S, Gerbaldo H: Auguste D and Alzheimer's disease. Lancet 1997;349:1546-1549.
4. Alzheimer A: Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr 1907;64:146-148.
5. Morris JC, Heyman A, Mohs RC, Hughes JP, van BG, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I: Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
6. Stern Y, Folstein M, Albert M, Richards M, Miller L, Bylsma F, Lafleche G, Marder K, Bell K, Sano M: Multicenter study of predictors of disease course in Alzheimer disease (the 'predictors study'). I. Study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord 1993;7:3-21.
7. Stern RG, Mohs RC, Davidson M, Schmeidler J, Silverman J, Kramer-Ginsberg E, Searcey T, Bierer L, Davis KL: A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 1994;151:390-396.
8. McLachlan DR, Dalton AJ, Galin H, Schlotterer G, Daicar E: Alzheimer's disease: clinical course and cognitive disturbances. Acta Neurol Scand Suppl 1984;99:83-89.
9. Mack JL, Whitehouse PJ: Quality of life in dementia: state of the art-report of the international working group for harmonization of dementia drug guidelines and the Alzheimer's society satellite meeting. Alzheimer Dis Assoc Disord 2001;15:69-71.
10. Albert SM, Jacobs DM, Sano M, Marder K, Bell K, Devanand D, Brandt J, Albert M, Stern Y: Longitudinal study of quality of life in people with advanced Alzheimer's disease. Am J Geriatr Psychiatry 2001;9:160-168.
11. Gonzalez-Salvador T, Lyketsos CG, Baker A, Hovanec L, Roques C, Brandt J, Steele C: Quality of life in dementia patients in long-term care. Int J Geriatr Psychiatry 2000;15:181-189.
12. Schneider J, Murray J, Banerjee S, Mann A: EUROCARE: a cross-national study of coresident spouse carers for people with Alzheimer's disease. I:-Factors associated with carer burden. Int J Geriatr Psychiatry 1999;14:651-661.
13. Ernst RL, Hay JW, Fenn C, Tinklenberg J, Yesavage JA: Cognitive function and the costs of Alzheimer disease: an exploratory study. Arch Neurol 1997;54:687-693.
14. Jonsson L, Eriksdotter JM, Kilander L, Soininen H, Hallikainen M, Waldemar G, Nygaard H, Andreasen N, Winblad B, Wimo A: Determinants of costs of care for patients with Alzheimer's disease. Int J Geriatr Psychiatry 2006;21:449-459.
15. Hux MJ, O'Brien BJ, Iskedjian M, Goeree R, Gagnon M, Gauthier S: Relation between severity of Alzheimer's disease and costs of caring. CMAJ 1998;159:457-465.
16. Birks J: Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 2006;CD005593.
17. Winblad B, Jelic V: Long-term treatment of Alzheimer disease: efficacy and safety of acetylcholinesterase inhibitors. Alzheimer Dis Assoc Disord 2004;18(suppl 1):S2-S8.
18. Ritchie CW, Ames D, Clayton T, Lai R: Meta-analysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease. Am J Geriatr Psychiatry 2004;12:358-369.
19. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ: Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003;348:1333-1341.
20. Winblad B, Poritis N: Memantine in severe dementia: results of the 9M-Best Study (benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry 1999;14:135-146.
21. Schneider LS: New therapeutic approaches to cognitive impairment. J Clin Psychiatry 1998;59(suppl 11):8-13.
22. Bianchetti A, Zanetti O, Trabucchi M: Non pharmacological treatment in Alzheimer's disease. Funct Neurol 1997;12:215-217.
23. Cohen-Mansfield J, Mintzer JE: Time for change: the role of nonpharmacological interventions in treating behavior problems in nursing home residents with dementia. Alzheimer Dis Assoc Disord 2005;19:37-40.
24. Cohen-Mansfield J: Nonpharmacologic interventions for inappropriate behaviors in dementia: a review, summary, and critique. Am J Geriatr Psychiatry 2001;9:361-381.
25. Bank AL, Arguelles S, Rubert M, Eisdorfer C, Czaja SJ: The value of telephone support groups among ethnically diverse caregivers of persons with dementia. Gerontologist 2006;46:134-138.
26. Wood W, Harris S, Snider M, Patchel SA: Activity situations on an Alzheimer's disease special care unit and resident environmental interactions, time use, and affect. Am J Alzheimers Dis Other Demen 2005;20:105-118.
27. Sierpina VS, Sierpina M, Loera JA, Grumbles L: Complementary and integrative approaches to dementia. South Med J 2005;98:636-645.
28. Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B: A family intervention to delay nursing home placement of patients with Alzheimer disease: a randomized controlled trial. JAMA 1996;276:1725-1731.
29. Lopez-Bastida J, Serrano-Aguilar P, Perestelo-Perez L, Oliva-Moreno J: Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain. Neurology 2006;67:2186-2191.
30. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 1988;24:641-652.
31. Lopez OL, Becker JT, Saxton J, Sweet RA, Klunk W, DeKosky ST: Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition. J Am Geriatr Soc 2005;53:83-87.
32. Lopez OL, Becker JT, Wisniewski S, Saxton J, Kaufer DI, DeKosky ST: Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002;72:310-314.
33. Bellelli G, Lucchi E, Minicuci N, Rozzini L, Bianchetti A, Padovani A, Trabucchi M: Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the 'real world' (CRONOS project): a 36-week follow-up study. Aging Clin Exp Res 2005;17:54-61.
34. Rikkert MG, Lauque S, Frolich L, Vellas B, Dekkers W: The practice of obtaining approval from medical research ethics committees: a comparison within 12 European countries for a descriptive study on acetylcholinesterase inhibitors in Alzheimer's dementia. Eur J Neurol 2005;12:212-217.
35. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
36. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
37. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
38. Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
39. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW: Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914-919.
40. Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
41. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
42. Wimo A, et al: Evaluation of the healthcare resource utilization and caregiver time in anti-dementia drug trials: a quantitative battery; in Wimo A, et al (eds): Health Economics of Dementia. Chichester, Wiley, 1998, pp 465-499.
43. Jonsson L, Lindgren P, Wimo A, Jonsson B, Winblad B: The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model. Clin Ther 1999;21:1230-1240.
44. Zarit SH, Todd PA, Zarit JM: Subjective burden of husbands and wives as caregivers: a longitudinal study. Gerontologist 1986;26:260-266.
45. Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, Kurz A: Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am J Geriatr Psychiatry 2006;14:139-144.
46. Rocca WA, Amaducci LA, Schoenberg BS: Epidemiology of clinically diagnosed Alzheimer's disease. Ann Neurol 1986;19:415-424.
47. Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, Kukull WA: Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004;140:501-509.
48. Sambrook R, Herrmann N, Hebert R, McCracken P, Robillard A, Luong D, Yu A: Canadian Outcomes Study in Dementia: study methods and patient characteristics. Can J Psychiatry 2004;49:417-427.
49. Fritsch T, McClendon MJ, Smyth KA, Ogrocki PK: Effects of educational attainment and occupational status on cognitive and functional decline in persons with Alzheimer-type dementia. Int Psychogeriatr 2002;14:347-363.
50. Wilson RS, Li Y, Aggarwal NT, Barnes LL, McCann JJ, Gilley DW, Evans DA: Education and the course of cognitive decline in Alzheimer disease. Neurology 2004;63:1198-1202.
51. Wilson RS, Bennett DA, Gilley DW, Beckett LA, Barnes LL, Evans DA: Premorbid reading activity and patterns of cognitive decline in Alzheimer disease. Arch Neurol 2000;57:1718-1723.
52. Andel R, Vigen C, Mack WJ, Clark LJ, Gatz M: The effect of education and occupational complexity on rate of cognitive decline in Alzheimer's patients. J Int Neuropsychol Soc 2006;12:147-152.
53. Le CN, Auriacombe S, Letenneur L, Bergua V, Dartigues JF, Fabrigoule C: Influence of education on the pattern of cognitive deterioration in AD patients: the cognitive reserve hypothesis. Brain Cogn 2005;57:120-126.
54. Roe CM, Xiong C, Miller JP, Morris JC: Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis. Neurology 2007;68:223-228.
55. Juva K, Sulkava R, Erkinjuntti T, Ylikoski R, Valvanne J, Tilvis R: Staging the severity of dementia: comparison of clinical (CDR, DSM-III-R), functional (ADL, IADL) and cognitive (MMSE) scales. Acta Neurol Scand 1994;90:293-298.